Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Thats why researchers are exploring new approaches to fill these gaps
10.1007/s12291-024-01273-1 Indian J Clin Biochem
Praesent an modio Praesent eu odio ut nisi ullamcorper ultricies
Here we report the engineering and preclinical development of a bimodal molecule that integrates NMDA receptor antagonism with glucagon-like peptide-1 (GLP-1) receptor agonism to effectively reverse obesity, hyperglycaemia and dyslipidaemia in rodent models of metabolic disease
It belongs to the incretin family, signals that help the body manage post-meal glucose by increasing insulin at the right time and tempering excess sugar release from the liver
US$ 22.18
US$ 25.57
US$ 20.56
US$ 26.64
US$ 23.27
US$ 20.17
